InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by 임한일, Vice-Président. Officer active across 2 companies, notably 대원제약. In total, 4 disclosures have been recorded. Activity tracked since 11 March 2026. The latest transaction was disclosed on 11 March 2026 (Purchase). Regulator: DART (FSS). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Lim Han-il is the vice president at Daewon Pharmaceutical, a South Korean company specializing in the pharmaceutical industry. In his role, he oversees operations and contributes to the company's strategy, aiming to improve efficiency and profitability. His experience is valuable in guiding Daewon Pharmaceutical to new heights.